Fig. 1: The expression and prognostic significance of BRD9 in HCC. | Cell Death & Disease

Fig. 1: The expression and prognostic significance of BRD9 in HCC.

From: Bromodomain-containing protein 9 promotes the growth and metastasis of human hepatocellular carcinoma by activating the TUFT1/AKT pathway

Fig. 1: The expression and prognostic significance of BRD9 in HCC.The alt text for this image may have been generated using AI.

a qRT-PCR for BRD9 mRNA was performed in 110 pairs of HCC and matched adjacent non-tumor liver tissues. *P < 0.05 by t-test. b Western blot analysis of BRD9 was performed in 20 pairs of HCC tissues and matched adjacent non-tumor liver tissues. *P < 0.05 by t-test. c Representative IHC staining of BRD9 in HCC tissues and adjacent non-tumor liver tissues. IHC scores for BRD9 between HCC and adjacent non-tumor liver tissues were compared. Scale bar: 25 μm. n = 110, *P < 0.05 by t-test. d qRT-PCR and e western blotting were performed for BRD9 expression in the immortalized hepatocyte cell line LO2 and five HCC cell lines (HepG2, Hep3B, Huh7, MHCC97H, and HCCLM3). n = three independent experiments, *P < 0.05 by ANOVA. f Overall survival and g disease-free survival were compared between HCC cases with positive BRD9 staining and those with negative BRD9 staining.

Back to article page